| Patents for C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325) |
|---|
| 01/15/2002 | US6339082 Tricyclic compounds, preparation method and said method intermediates, application as medicines and pharmaceutical compositions containing same |
| 01/15/2002 | CA2028302C Benzimidazole derivatives, their production and use |
| 01/10/2002 | WO2002002533A1 Propane-1,3-dione derivatives |
| 01/10/2002 | WO2002002532A1 4-alkoxy cyclohexane-1 amino carboxylic acid esters and method for the production thereof |
| 01/10/2002 | DE10030664A1 Verfahren zur Herstellung von UV-Filter-Substanzen Process for the preparation of UV filter substances |
| 01/10/2002 | DE10030663A1 UV-B-Filter UV-B filters |
| 01/09/2002 | EP1170288A2 Diphenylureum derivatives and their use as alpha2/5-HT2c antagonists |
| 01/09/2002 | EP0607439B1 Nitrogenous heterocyclic compound |
| 01/09/2002 | CN1330677A Method for production of polyelectrolyte membranes and fuel cell |
| 01/09/2002 | CN1330641A Crystalline forms of 3-(2,4-dichlorobenzyl)-2-methyl-N-(pentylsulfonyl)-3H-benzimidzole-5-carboxamide |
| 01/09/2002 | CN1330640A Cyclic hydrazine derivatives as TNF-alpha inhibitors |
| 01/09/2002 | CN1077427C Skin protecting composition containing acid hydrophilic agent for cosmetic use and application of same |
| 01/03/2002 | WO2002102789A1 Antimicrobial and radioprotective compounds |
| 01/03/2002 | WO2002000614A1 Aryl compounds, their preparation and their use in therapy |
| 01/03/2002 | WO2001051473A8 1,2-diaryl benzimidazoles for treating illnesses associated with a microglia activation |
| 01/03/2002 | US20020002169 Protein kinase inhibitors |
| 01/03/2002 | DE10030375A1 Verwendung von MTP-Inhibitoren zur Senkung von ppTRL Use of MTP inhibitors to reduce ppTRL |
| 01/02/2002 | EP1167360A1 Human chymase inhibitors |
| 01/02/2002 | EP1167359A1 Process for the preparation of 2-arylbenzimidazole sulphonic acids and their use as UV-filters |
| 01/02/2002 | EP1167358A1 2-Phenylbenzimidazole sulphonic acids as UV-B filters |
| 01/02/2002 | EP1167357A1 Alpha-substituted carboxylic acid derivatives |
| 01/02/2002 | EP1165557A1 ARYL AND HETEROARYL FUSED AMINOALKYL-IMIDAZOLE DERIVATIVES: SELECTIVE MODULATORS OF GABAa RECEPTORS |
| 01/02/2002 | EP1165530A2 Dihetero-substituted metalloprotease inhibitors |
| 01/02/2002 | EP1165519A1 Aryl and heteroaryl fused aminoalkyl-imidazole derivatives and their use as antidiabetics |
| 01/02/2002 | EP1165518A2 Benzimidazole and imidazolopyridine derivatives, their preparation and their use as selective modulators of bradykinin b2 (= bk-2) receptors |
| 01/02/2002 | EP1165517A1 N-benzimidazolylmethyl- and n-indolylmethyl-benzamides and their use as crf modulators |
| 01/02/2002 | EP1165512A2 Method for arylating aza-heterocycles with activated aromatic compounds in the presence of cesium carbonate |
| 01/02/2002 | EP1165511A2 Method of producing heterocyclic carbamates from aza-heterocyclic compounds and carbon dioxide |
| 01/02/2002 | EP1165504A2 INHIBITORS OF LFA-1 BINDING TO ICAMs AND USES THEREOF |
| 01/02/2002 | CN1329601A New benzimidazolone-benzoxazolone-, or benzothiazolone derivatives as ion channel modulating agents |
| 01/02/2002 | CN1329281A Colour photosensitive imaging element containing closed developer |
| 01/01/2002 | US6335334 Hypertensive agents, anticoagulants; cardiovascular and sexual disorders, angina pectoris, and atherosclerosis |
| 12/27/2001 | WO2001097787A2 Use of microsomal triglyceride transfer protein (mtp) inhibitors for reducing the number of postprandial triglyceride-rich lipoprotein particles (pptrl) |
| 12/27/2001 | WO2001064659A3 Indane derivatives and their use as cell adhesion inhibitors |
| 12/27/2001 | US20010056100 Carboxylic acid or tetrazole derivatives containing carbamate groups are useful for treating the conditions associated with the urinary tract, pain, inflammation, respiratory states, edema formation of hypotensive vascular diseases |
| 12/27/2001 | CA2413277A1 Use of microsomal triglyceride transfer protein (mtp) inhibitors for reducing the number of postprandial triglyceride-rich lipoprotein particles (pptrl) |
| 12/20/2001 | WO2001096299A2 Indole derivatives and their use as 15-lipoxygenase inhibitors |
| 12/20/2001 | WO2001096289A1 Sulfonamide derivatives |
| 12/20/2001 | WO2001051456A3 Antibacterial agents |
| 12/20/2001 | US20010053856 Sunscreen agents; ultraviolet radiation absorber |
| 12/20/2001 | US20010053779 Antiinflammatory agents; respiratory system disorders |
| 12/20/2001 | CA2411811A1 Sulfonamide derivatives |
| 12/20/2001 | CA2411116A1 Indole derivatives and their use as 15-lipoxygenase inhibitors |
| 12/19/2001 | EP1164418A2 Color photothermographic elements comprising blocked developing agents |
| 12/19/2001 | EP1164134A1 Benzimidazole compounds and their use as modulators of the GABA A receptor complex |
| 12/19/2001 | EP1164121A1 Novel carboxylic acid derivatives and process for producing the same |
| 12/19/2001 | EP1163221A1 Sulfonamide derivatives as 5ht7 receptor antagonists |
| 12/19/2001 | EP1094816A4 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 12/18/2001 | US6331640 Diaminopropionic acid derivatives |
| 12/18/2001 | US6331563 N-Hydroxy-2-(Alkyl, Aryl, or Heteroaryl, Sulfanyl, Sulfinyl or Sulfonyl)-3-Substituted Alkyl, Aryl or Heteroarylamides as Matrix Metalloproteinase inhibitors |
| 12/18/2001 | CA2204290C Benzimidazole derivatives, their production and use |
| 12/18/2001 | CA2160725C Process for the preparation of a tetrazole derivative in two crystalline forms and novel crystalline form of said derivative |
| 12/13/2001 | WO2001094341A1 Quinazoline derivatives for the treatment of tumours |
| 12/13/2001 | WO2001094321A1 Bicyclic cyclohexylamines and their use as nmda receptor antagonists |
| 12/13/2001 | WO2001094317A2 Method for synthesis of substituted azole libraries |
| 12/13/2001 | CA2407164A1 Bicyclic cyclohexylamines and their use as nmda receptor antagonists |
| 12/13/2001 | CA2345195A1 Color photothermographic elements comprising blocked developing agents |
| 12/12/2001 | EP1162196A1 Fused-ring compounds and use thereof as drugs |
| 12/12/2001 | EP0781126B1 Derivatives of 2-amino-1,2,3,4-tetrahydro-naphthalene active on the cardiovascular system |
| 12/11/2001 | US6329360 Hetero-linked phenylglycinolamides |
| 12/06/2001 | WO2001092239A1 Biciclic cyclohexylamines and their use as nmda receptor antogonists |
| 12/06/2001 | US20010049447 2-(-2-(N-(3-benzoimidazol-2-yl)propyl)-N-methylamino)ethyl)-6-fluoro -1,2,3,4-tetrahydro-1-isopropyl-2-napthyl-esters; antidiabetic agents and treats microvascular or macrovascular diseases associated with diabetes. |
| 12/06/2001 | US20010049446 C-C9-Heteroaryl, linked via C or N, substituted or unsubstitued by 1,3-substituents, substituted benzoylguanidine derivatives useful for treating ischemia, cardiac infarct, angina pectoris, and storke etc. |
| 12/06/2001 | US20010049385 Treating obesity; suppressing appetite; treating type 2 diabetes; treatment and/or prevention of diseases and disorders related to the histamine H3 receptor. |
| 12/06/2001 | CA2409006A1 Biciclic cyclohexylamines and their use as nmda receptor antogonists |
| 12/05/2001 | EP1159237A1 Method of preparing surface-active alcohols and surface-active alcoholic ethers, products obtained by said method and their use |
| 12/05/2001 | EP0821684B1 Benzimidazole compounds and their use as modulators of the gaba a? receptor complex |
| 12/05/2001 | EP0643701B1 Benzimidazole-derived compounds, method for preparing same, and therapeutical and cosmetic uses thereof |
| 12/05/2001 | CN1325397A 2-piperazino alkylatnino benzoazole derivatives: dopamine receptor subtype sepcific ligands |
| 12/05/2001 | CN1325376A Novel compounds and medicinal use thereof |
| 12/05/2001 | CN1325308A Use of neurotrophic factor stimulators for treatment of ophthalmic neurodegenerative diseases |
| 12/05/2001 | CN1325267A Fused-benzene derivatives useful as herbicides |
| 12/04/2001 | USH2007 Insecticidal N-heterocyclylalkyl-or N-[(polycyclyl)alkyl]-N′substituted piperazines |
| 12/04/2001 | US6326403 Cardiovascular disorders |
| 12/04/2001 | US6326395 Amidine or amide substituted furan derivatives |
| 12/04/2001 | US6326384 Dry blend pharmaceutical unit dosage form |
| 12/04/2001 | US6326369 Bicyclic quinone compounds, their production and use |
| 12/04/2001 | US6326133 Cyanine dyes |
| 11/29/2001 | WO2001090074A2 BENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a) |
| 11/29/2001 | US20010047038 Treating the patient suffering for herpes viruses, and cytomegalovirus with an effective amount of sulfur or sulfoxide or sulfonyl containing heteroaromatic compounds |
| 11/29/2001 | US20010047021 Tetrasubstituted benzimidazole carbamates |
| 11/29/2001 | US20010047020 Benzimidazole derivatives, their production and use |
| 11/29/2001 | CA2408727A1 Benzophenones as inhibitors of il-1.beta. and tnf-.alpha. |
| 11/28/2001 | EP0830344B1 2-substituted benzimidazole derivatives as smooth muscle cell proliferation inhibitors |
| 11/28/2001 | CN1323788A 2-pyrimidyloxy-N-amidophynylbenzyl amine, and its prepn. and use |
| 11/27/2001 | US6323227 Prodrugs |
| 11/22/2001 | WO2001087859A1 Naphthol derivatives |
| 11/22/2001 | US20010044468 Reduced in the body to produce a benzamidine; nontoxic |
| 11/22/2001 | US20010044441 And female sexual dysfunction, premature labour or dysmenorrhea |
| 11/21/2001 | EP1156043A2 Drugs that enhance synaptic responses mediated by ampa receptors |
| 11/21/2001 | EP1155025A1 Platinum (ii) compounds |
| 11/21/2001 | EP1154771A1 Nitrosated and nitrosylated proton pump inhibitors, compositions and methods of use |
| 11/21/2001 | EP0914319B1 Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists |
| 11/21/2001 | EP0831910B1 Epoxy-steroidal aldosterone antagonist and angiotensin ii antagonist combination therapy for treatment of congestive heart failure |
| 11/21/2001 | EP0742210B1 2-mercaptobenzimidazole derivative and antihyperlipemic or antiarteriosclerotic agent containing the same |
| 11/21/2001 | CN1323291A Diaminopropionic acid derivatives |
| 11/21/2001 | CN1323289A Aminoalcohol derivatives and their use as beta 3 adrenergic agonists |
| 11/15/2001 | US20010041730 (1S,2S)-2-(2-(N-((3-benzoimidazol-2-yl)propyl)-N-methylamino)ethyl)-6 -fluoro-1,2,3,4-tetrahydro-1-isopropyl-2-naphthyl cyclopropanecarboxylate, for example; treating vascular disease such as gangrene, retinopathy, nephropathy |
| 11/14/2001 | EP1153017A1 Bicyclic compounds and their use as integrin receptor ligands |
| 11/13/2001 | US6316634 Method for preparing cycloheptimidazoles |